Novel therapeutic strategies in the treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is defined by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Treating patients with TNBC remains clinically challenging, as patients are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Oualla, Karima, El-Zawahry, Heba M., Arun, Banu, Reuben, James M., Woodward, Wendy A., Gamal El-Din, Heba, Lim, Bora, Mellas, Nawfel, Ueno, Naoto T., Fouad, Tamer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502951/
https://www.ncbi.nlm.nih.gov/pubmed/28717401
http://dx.doi.org/10.1177/1758834017711380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502951/
https://www.ncbi.nlm.nih.gov/pubmed/28717401
http://dx.doi.org/10.1177/1758834017711380

Ejemplares similares